 |
Aldesleukin |
|---|---|
| Trade Name | Proleukin |
| Orphan Indication | Primary immunodeficiency disease associated with T-cell defects |
| USA Market Approval | USA |
| USA Designation Date | 1989-03-22 00:00:00 |
| Sponsor | Prometheus Laboratories, Inc.;9410 Carroll Park Drive;San Diego, California, 92121 |
